SCHEMBL25540646

SCHEMBL25540646

Nc1cc(-c2ccccc2)c(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)ccc32)c(-c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ATM Q13315 1/20 0.49
IL1R1 P14778 1/20 0.39
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
TSPO P30536 1/20 0.36
HDAC4 P56524 1/20 0.36
HSD17B10 Q99714 2/20 0.35
HPGD P15428 2/20 0.35
MAPK1 P28482 1/20 0.35
HBB P68871 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTGER4 P35408 1/20 0.34
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540501 0.93 TSPO (0.40) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL25540554 0.92 KDM4E (0.39) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL25540505 0.89 KDM4E (0.43) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL15502483 0.87 L3MBTL1 (0.53) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL25540649 0.86 L3MBTL1 (0.49) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL19729740 0.86 L3MBTL1 (0.51) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL19729689 0.85 L3MBTL1 (0.50) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL12443220 0.84 KDM4E (0.56) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL23177545 0.84 L3MBTL1 (0.49) KDM4EL3MBTL1ATMIL1R1ALDH1A1
SCHEMBL15926655 0.84 KDM4E (0.49) KDM4EL3MBTL1ATMIL1R1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CYP1A1, NQO1 KDM4E 3633/4885L3MBTL1 1368/4885ATM 3960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.